Atlas FDA

GEM215 Growth Factor Enhanced Matrix

FDA premarket approval P040013/S023 · decided 2020-06-17

Approval details

PMA number
P040013
Supplement
S023
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
GEM215 Growth Factor Enhanced Matrix
Generic name
Bone grafting material, dental, with biologic component
Applicant
Lynch Biologics, LLC
Date received
2020-03-24
Decision date
2020-06-17
Days to decision
85 days
Decision code
APPR
Product code
NPZ
Advisory committee
Dental
Expedited review
No
Location
Franklin, TN
Statement
Approval for change of the supplier from STERIS (formerly Synergy Health) in Swindon, United Kingdom (STERIS Swindon), to the STERIS AST facility located at 9 Apollo Drive, Whippany, New Jersey, United States (STERIS Whippany), for sterilization of the ?-TCP cup component of the GEM21S device.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.